BMSSC
PRCT icon

B. Metzler seel. Sohn & Co’s Procept Biorobotics PRCT Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,200
Closed -$1.86M – 741
2025
Q4 		$1.86M Buy
+59,200
New +$1.96M 0.02% 424

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

B. Metzler seel. Sohn & Co's PRCT Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 59,200 shares — an estimated $1.86M sold.

B. Metzler seel. Sohn & Co first reported a position in PRCT in Q4 2025 and held it in 1 quarter. The position peaked at $1.86M in Q4 2025. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • B. Metzler seel. Sohn & Co reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 59,200 Procept Biorobotics shares in Q1 2026, an estimated $1.86M.
  • B. Metzler seel. Sohn & Co first reported a position in Procept Biorobotics in Q4 2025 and held it in 1 quarter.
  • B. Metzler seel. Sohn & Co's Procept Biorobotics position peaked at $1.86M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.